Thyrocare Promoter Sells 9.90% Stake, Holding Falls to 51.02%
Thyrocare Technologies Limited disclosed that it received information from Docon Technologies Private Limited regarding the sale of 1,57,69,696 equity shares of the company through market trades on August 13, 2026.
The shares sold represent approximately 9.90% of Thyrocare's total paid-up equity share capital. The settlement of the transaction will be carried out in accordance with applicable laws and regulations.
Thyrocare Promoter Shareholding Impact
Following the transaction, the overall promoter shareholding in Thyrocare Technologies declined from 60.92% to 51.02% of the total paid-up equity share capital.
Despite the sale, Docon Technologies continues to be classified as a promoter and holding company of Thyrocare. The transaction therefore reduces the promoter group's stake while maintaining Docon Technologies' promoter status.
Thyrocare Regulatory Disclosure and Company Context
Thyrocare Technologies made the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates in the healthcare services sector and has a market capitalization of approximately Rs. 10,233.5 crore.
The promoter share sale represents a significant change in the promoter group's holding in the company, although the promoter group continues to hold a majority stake after the transaction.
Thyrocare Promoter Share Sale Highlights
- Promoter: Docon Technologies Private Limited.
- Shares Sold: 1,57,69,696 equity shares.
- Transaction Type: Market trade.
- Transaction Date: August 13, 2026.
- Percentage of Paid-up Equity Capital Sold: Approximately 9.90%.
- Promoter Shareholding Before Sale: 60.92%.
- Promoter Shareholding After Sale: 51.02%.
- Promoter Status: Docon Technologies continues to remain a promoter and holding company of Thyrocare.
- Settlement: The transaction will be settled in accordance with applicable laws and regulations.
- Regulatory Disclosure: Disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Market Capitalization: Approximately Rs. 10,233.5 crore.
What to Watch Next
- Investors may track whether Docon Technologies or other promoter group entities make any further share sales or purchases in Thyrocare.
- They may monitor changes in the overall promoter shareholding following this transaction.
- Investors may also watch whether Docon Technologies continues to maintain its promoter and holding company status.
- Future regulatory disclosures may provide details of any additional changes in the promoter group's stake.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Ace Software Exports: Promoter Sells 1.34 Lakh Shares in Open Market
Vashali Amit Mehta, a promoter of Ace Software Exports Limited, disclosed the sale of 1,34,379 equity shares through open market transactions between August 4, 2026, and August 11, 2026. The sale included 42,120 fully paid-up shares and 92,259 partly paid-up shares. Following the transaction, her shareholding declined from 4.94% to 4.39% of the company's total share capital.
Sharp India Limited: G. D. Apte & Co. Steps Down as Statutory Auditor Mid-Term
Sharp India Limited has informed exchanges that its statutory auditor, G. D. Apte & Co., is resigning midway through its term. The exit takes effect August 13, 2026.
Amit International: Mirant Raju Shah Disposes 1.45 Lakh Shares
Mirant Raju Shah, identified as 'Seller 3', disclosed the disposal of 1,44,824 equity shares of Amit International Limited through an off-market transaction on August 10, 2026. The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.